Translation and validation of an Iranian version of the Diabetes Quality of Life measure

Journal of Diabetes Investigation

Volumn 3, Issue 5, 2012, Pages 471-478

  Pakpour, Amir H ^a   Saffari, Mohsen ^b   Burri, Andrea ^c  

^a QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetes Quality of Life; Type 2 diabetes; Validity

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CONSTRUCT VALIDITY; CONVERGENT VALIDITY; CRONBACH ALPHA COEFFICIENT; DIABETES QUALITY OF LIFE QUESTIONNAIRE; FACTORIAL ANALYSIS; FACTORIAL VALIDITY; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERNAL RELIABILITY; IRAN; LANGUAGE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SHORT FORM 36; VALIDATION STUDY; VALIDITY;

EID: 84867803902     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2012.00217.x     Document Type: Article

References (50)

1. Sriwijitkamol A, Moungngern Y, Vannaseang S. Assessment and prevalences of diabetic complications in 722 Thai type 2 diabetes patients. J Med Assoc Thai 2011; 94: 168-174.
2. Calvin D, Quinn L, Dancy B, et al. African Americans' perception of risk for diabetes complications. Diabetes Educ 2011; 37: 689-698.
3. Walgate R. Diabetes research for developing countries. N Biotechnol 2008; 25: 111-116.
4. Zhang L, Zhang WH, Zhang L, et al. Prevalence of overweight/obesity and its associations with hypertension, diabetes, dyslipidemia, and metabolic syndrome: a survey in the suburban area of Beijing, 2007. Obes Facts 2011; 4: 284-289.
5. Steinbrecher A, Erber E, Grandinetti A, et al. Physical activity and risk of type 2 diabetes among native Hawaiians, Japanese Americans, and Caucasians: the multiethnic cohort. J Phys Act Health 2011; in press.
6. WHO. World Health Organization factsheets about diabetes. Available at http://www.who.int/mediacentre/factsheets/fs312/en (accessed 20 October 2011).
7. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
8. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
9. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
10. Hadaegh F, Bozorgmanesh MR, Ghasemi A, et al. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran lipid and glucose study. BMC Public Health 2008; 8: 176.
11. Claassen L, Henneman L, Nijpels G, et al. Causal beliefs and perceptions of risk for diabetes and cardiovascular disease, the Netherlands, 2007. Prev Chronic Dis 2011; 8: A130.
12. Glover SJ, Burgess PI, Cohen DB, et al. Prevalence of diabetic retinopathy, cataract and visual impairment in patients with diabetes in sub-Saharan Africa. Br J Ophthalmol 2011; doi:10.1136/bjo.2010.196071.
13. Sundling V, Platou CG, Jansson RW, et al. Retinopathy and visual impairment in diabetes, impaired glucose tolerance and normal glucose tolerance: the Nord-Trondelag Health Study (the HUNT study). Acta Ophthalmol 2010; doi:10.1111/j.1755-3768.2010.01998.x.
14. Charles M, Ejskjaer N, Witte DR, et al. Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care 2011; 34: 2244-2249.
15. Abate N, Chandalia M. The impact of ethnicity on type 2 diabetes. J Diabetes Complications 2003; 17: 39-58.
16. Lindsay G, Inverarity K, McDowell JR. Quality of life in people with type 2 diabetes in relation to deprivation, gender, and age in a new community-based model of care. Nurs Res Pract 2011; doi:10.1155/2011/613589.
17. Akinci F, Yildirim A, Gözü H, et al. Assessment of health-related quality of life (HRQoL) of patients with type 2 diabetes in Turkey. Diabetes Res Clin Pract 2008; 79: 117-123.
18. Westaway MS, Rheeder P, Gumede T. The effect of type 2 diabetes mellitus on health-related quality of life (HRQOL). Curationis 2001; 24: 74-78.
19. Efficace F, Bottomley A. Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer 2002; 38: 1824-1831.
20. Burroughs TE, Desikan R, Waterman BM, et al. Development and validation of the Diabetes Quality of Life brief clinical inventory. Diabetes Spectrum 2004; 17: 41-49.
21. Pickup JC, Harris A. Assessing quality of life for new diabetes treatments and technologies: a simple patient-centered score. J Diabetes Sci Technol 2007; 1: 394-399.
22. Carey MP, Jorgensen RS, Weinstock RS, et al. Reliability and validity of the appraisal of diabetes scale. J Behav Med 1991; 14: 43-51.
23. Bradley C, Todd C, Gorton T, et al. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999; 8: 79-91.
24. Fitzpatrick R, Davey C, Buxton MJ, et al. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998; 2: 1-74.
25. Shen W, Kotsanos JG, Huster WJ, et al. Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire. Med Care 1999; 37: AS45-AS66.
26. Bott U, Mühlhauser I, Overmann H, et al. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care 1998; 21: 757-769.
27. Hirsch A, Bartholomae C, Volmer T. Dimensions of quality of life in people with non-insulin-dependent diabetes. Qual Life Res 2000; 9: 207-218.
28. Hammond GS, Aoki TT. Measurement of health status in diabetic patients diabetes impact measurement scales. Diabetes Care 1992; 15: 469-477.
29. Jacobson A, Barofsky I, Cleary P, Rand L. The diabetes control and complications trial: reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). Diabetes Care 1988; 11: 725-732.
30. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type 1 and type 2 diabetes. Diabetes Care 1994; 17: 267-274.
31. Davis TM, Clifford RM, Davis WA, et al. Fremantle diabetes study effect of insulin therapy on quality of life in type 2 diabetes mellitus: the fremantle diabetes study. Diabetes Res Clin Pract 2001; 52: 63-71.
32. Chesla CA, Fisher L, Mullan JT, et al. Family and disease management in African-American patients with type 2 diabetes. Diabetes Care 2004; 27: 2850-2855.
33. Ware JE, Sherbourne CD. The MOS 36-Item health survey (SF-36) I. conceptual framework and item selection. Med Care 1992; 30: 473-483.
34. Montazeri A, Goshtasebi A, Vahdaninia M, et al. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res. 2005; 14: 875-882.
35. Germin-Petrović D, Mesaros-Devcić I, Lesac A, et al. Health-related quality of life in the patients on maintenance hemodialysis: the analysis of demographic and clinical factors. Coll Antropol 2011; 35: 687-693.
36. Peyrot M, Rubin RR. Patient-reported outcomes in adults with type 2 diabetes using mealtime inhaled technosphere insulin and basal insulin versus premixed insulin. Diabetes Technol Ther 2011; 13: 1201-1206.
37. Beaton DE, Bombardier C, Guillemin F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000; 25: 3186-3191.
38. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
39. Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep 1966; 19: 3-11.
40. Huang IC, Liu JH, Wu AW, et al. Evaluating the reliability, validity and minimally important difference of the Taiwanese version of the Diabetes Quality of Life (DQOL) measurement. Health Qual Life Outcomes 2008; 6: 87.
41. Jacobson AM, de Groot M, Samson JA. The effects of psychiatric disorders and symptoms on quality of life in patients with type 1 and type 2 diabetes mellitus. Qual Life Res 1994; 6: 11-20.
42. Redekop WK, Koopmanschap MA, Stolk RP, et al. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002; 25: 458-463.
43. Brown DW, Balluz LS, Giles WH, et al. Diabetes mellitus and health related quality of life among older adults findings from the behavioral risk factor surveillance system (BRFSS). Diabetes Res Clin Pract 2004; 65: 105-115.
44. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289-300.
45. Byrne BM. Structural Equation Modelling. Lawrence Erlbaum Associates Publishers, Mahwah, NJ, 1998.
46. Yildirim A, Akinci F, Gozu H, et al. Translation, cultural adaptation, cross-validation of the Turkish diabetes quality-of-life (DQOL) measure. Qual Life Res 2007; 16: 873-879.
47. Goddijn PP, Bilo HJ, Feskens EJ, et al. Longitudinal study on glycaemic control and quality of life in patients with type 2 diabetes mellitus referred for intensified control. Diabet Med 1999; 16: 23-30.
48. Van der Does FEE, de Neeling JND, Snoek FJ, et al. Symptoms and well-being in relation to glycemic control in type 2 diabetes. Diabetes Care 1996; 19: 204-210.
49. Jöreskog KG, Sörbom D. LISREL Version 8.54: User's Reference Guide [Electronic Manual]. Scientific Software International Inc, Chicago, IL, 2003.
50. Maymone AC, Baillargeon JP, Ménard J, et al. Oral hypoglycemic agents for gestational diabetes mellitus?Expert Opin Drug Saf 2011; 10: 227-238.